APA (7th ed.) Citation

Kohnosuke Kinoshita, Motoki Ochi, Katsuya Iwata, Misako Fukasawa, & Jun‐ichi Yamaguchi. (2019). Preclinical disposition of MGS0274 besylate, a prodrug of a potent group II metabotropic glutamate receptor agonist MGS0008 for the treatment of schizophrenia. Wiley.

Chicago Style (17th ed.) Citation

Kohnosuke Kinoshita, Motoki Ochi, Katsuya Iwata, Misako Fukasawa, and Jun‐ichi Yamaguchi. Preclinical Disposition of MGS0274 Besylate, a Prodrug of a Potent Group II Metabotropic Glutamate Receptor Agonist MGS0008 for the Treatment of Schizophrenia. Wiley, 2019.

MLA (9th ed.) Citation

Kohnosuke Kinoshita, et al. Preclinical Disposition of MGS0274 Besylate, a Prodrug of a Potent Group II Metabotropic Glutamate Receptor Agonist MGS0008 for the Treatment of Schizophrenia. Wiley, 2019.